Last updated: May 2026
Global rank: Worldwide · 2026-04
#3,821,440
AI visibility: Grade C
67
SEO health: Latest audit
0
Visits
64
per month, estimated
Keywords
1
ranking in Google
Organic share
100%
64 organic visits
LLMS.txt
Published
165 lines AI engines can read
You're seeing the free preview of ausperbio.com
ausperbio.com Web Traffic Statistics
Key findings
- Ausperbio (Healthcare, Life Sciences & Wellness) is ranked #3,821,440 worldwide in our April 2026 domain ranking.
- It is estimated to receive about 64 visits a month from search, 100% of it organic, across 1 ranking keywords.
- Its AI visibility score is 67 out of 100 (grade C), with a published llms.txt of 165 lines.
- Its last technical audit scored 0/100, with "Implement Title and Meta Description" the highest-priority fix.
What this company does
Ausperbio stands at the forefront of biopharmaceutical innovation as a Phase II clinical-stage company zeroed in on cracking the code for Hepatitis B virus (HBV) cure. Their proprietary Med-Oligo™ antisense oligonucleotide (ASO) platform pairs cutting-edge chemistry with smart delivery tech to hit disease targets precisely, minimizing side effects that plague traditional therapies. This approach isn't just about HBV—…
Our read on the site
The overall SEO health of https://ausperbio.com is critically poor, with missing essential on-page elements such as title, meta description, and H1 tags. Additionally, technical aspects like the absence of a viewport meta tag, robots.txt, and sitemap.xml further hinder the site's SEO performance.
ausperbio.com Traffic and Visitor Engagement
Search engines send ausperbio.com an estimated 64 visits a month. Effectively all of it is organic — about 64 visits from unpaid results. Spread across 1 ranking keywords, that averages roughly 64 organic visits per keyword.
Monthly visits
64
Latest estimate
Change
No monthly history yet
It starts building from the first scan
Organic visits
64
100% of all traffic
Paid visits
0
No paid search detected
Organic vs paid
100%
0%
We don't hold a month-by-month history for this domain yet.
The traffic dashboard builds one from the first scan onwards.
ausperbio.com AI Visibility
ausperbio.com scores 67 out of 100 on our AI visibility scale, grade C. It takes full marks for LLMS.txt and Structured data. The biggest gap is SEO health, at 0 of 20 points (0/100), worth 20 points if closed. It also loses points on Crawlability (0/10) and Company profile (22/25).
Grade C
Scored from this domain's own data — llms.txt, profile completeness, technical health, crawlability and structured data.
Present
7/8 core fields
0/100
robots ✗ · sitemap ✗
Detected
Fix these first
- → Complete your company profile so AI answers about you stay accurate.
- → Add robots.txt and sitemap.xml so AI crawlers can read you.
ausperbio.com LLMS.txt
The llms.txt on ausperbio.com runs to 165 lines (8,176 characters) across 12 sections, last generated in May 2026. It introduces the site as "Ausperbio". It tells AI engines the business works in Biotechnology, Pharmaceuticals and Clinical Research. It describes 5 products, including Med-Oligo™ HBV ASO, Med-Oligo™ Platform and Targeted Delivery Systems. Services it lists include ASO Platform Licensing, Collaborative R&D, Clinical Trial Services and Delivery Tech Consulting. The audience it names is Healthcare professionals, biotech investors, HBV patients (Global). Technologies it mentions include HTTPS. The keywords it claims start with "Ausperbio", "HBV cure", "Med-Oligo" and "ASO therapeutics".
Status
Published
AI engines can read it
Lines
165
In the file
Size
8.2K
Characters
Sections
12
Updated May 10, 2026
What the file says
# Ausperbio ## About Ausperbio is pushing boundaries in biopharma with their Phase II clinical-stage focus on curing Hepatitis B through the game-changing Med-Oligo™ ASO platform. This tech combines potent antisense oligonucleotides with precise delivery mechanisms to attack HBV at its core, aiming for the functional cures that have eluded the field for decades. Their work extends to metabolic diseases, genetic disorders, immune conditions, and more, leveraging a platform ripe for multiple indications. What sets them apart is the emphasis on safe, targeted delivery that gets therapies exactly where needed, reducing off-target risks and boosting efficacy. In a market dominated by suppressive antivirals, Ausperbio's curative ambition fills a critical gap for the 250+ million chronic HBV sufferers globally. Their R&D engine churns out candidates with solid preclinical data transitioning smoothly to human trials. Partnerships with delivery tech innovators amplify their edge, while a lean team of oligo experts drives efficiency. Regulatory savvy has them on track for key readouts soon, exciting the investment community. For patients, this means real hope for life without daily pills or constant monitoring. Ausperbio's vision reimagines oligonucleotide meds as everyday powerhouses against hard-to-treat diseases. **Areas of Work:** Biotechnology, Pharmaceuticals, Clinical Research
Sections in the file
Areas of work
Keywords it claims
Technologies
Products it tells AI about
- Med-Oligo™ HBV ASOContact for pricing
- Med-Oligo™ PlatformLicensing available
- Targeted Delivery SystemsContact for pricing
- Metabolic Disease ASOsContact for pricing
- Genetic Disorder TherapeuticsContact for pricing
Services it tells AI about
- ASO Platform Licensing
- Collaborative R&D
- Clinical Trial Services
- Delivery Tech Consulting
- HBV Biomarker Development
Competitors it names
Audience it targets
Healthcare professionals, biotech investors, HBV patients · Global
Company type
Private
ausperbio.com Organic Keywords
Google lists ausperbio.com for about 1 keywords, which together bring an estimated 64 organic visits a month.
Ranking keywords
1
Found in Google for this domain
Visits they bring
64
Estimated organic visits a month
Top ranking keywords
No ranked-keyword data cached for this domain yet.
Ranked Keywords pulls the full list on its first run.
What it ranks for
ausperbio.com SEO Audit
The latest technical audit of ausperbio.com scored 0 out of 100 overall. The audit makes 12 recommendations in all, and 4 of the 4 listed first are rated high priority or critical.
Overall
SEO
Performance
Accessibility
Fix these first
- CriticalImplement Title and Meta Description
- CriticalAdd H1 Tags
- HighImplement Viewport Meta Tag
- HighCreate Robots.txt File
8 more recommendations, with the exact changes and the pages they apply to, are in the full report.
ausperbio.com Competitors and Alternatives
Ausperbio's company profile names https://www.ionis.com, https://www.alnylam.com, https://www.sarepta.com and https://www.biogen.com as competitors. Its own llms.txt adds https://www.arrowheadpharma.com, https://www.vir.bio and https://www.gilead.com. Outside its market, the domains ranked closest to it in our worldwide ranking are coverspool.com, jobwiki.ir, mhq.ch and sunkrad.jp.
ausperbio.com Company Profile
Ausperbio stands at the forefront of biopharmaceutical innovation as a Phase II clinical-stage company zeroed in on cracking the code for Hepatitis B virus (HBV) cure. Their proprietary Med-Oligo™ antisense oligonucleotide (ASO) platform pairs cutting-edge chemistry with smart delivery tech to hit disease targets precisely, minimizing side effects that plague traditional therapies. This approach isn't just about HBV—…
Ausperbio was founded in 2018, about 8 years ago. Its workforce is listed as between 11 and 50 employees. Its profile files it under Healthcare, Life Sciences & Wellness, with further tags for Biotechnology, Biopharma, Clinical Stage and Antisense Oligonucleotides. The product on record for it: Med-Oligo™ ASO Platform. Its tagline reads: "Transforming HBV treatment for cure through innovative Med-Oligo™ ASO platform".
- Sector
- Healthcare, Life Sciences & Wellness
- Founded
- 2018
- Employees
- 11-50
- Revenue
- Not Disclosed
- Funding
- Not Disclosed
- Products
- Med-Oligo™ ASO Platform
ausperbio.com Traffic by Country
Which markets this brand actually serves, and where the web links to it from.
Top customer markets
AI estimate · live webWe only measure visitor geography for domains whose analytics are connected to us. For everyone else this is read live from the web and shown as an estimate — never mixed in with the measured numbers.
No market breakdown available for this brand.
Where its backlinks come from
Measured. The country each linking site is hosted in — a real signal of which regions know this brand.
No backlink sample for this domain yet.
Backlink Analytics collects one on its first run.
ausperbio.com Backlink Analytics
Who vouches for this domain. Strong, varied links are still the clearest signal of authority — to search engines and to AI engines that cite sources.
We haven't run a backlink crawl for ausperbio.com yet, so there are no link counts to show. Backlink Analytics builds the profile on its first run and it appears here after that.
—
links on file
Companies ranked next to ausperbio.com
Neighbours of #3,821,440 in our worldwide ranking — each with its own report.
Wait — let's zoom out.
You are looking at one domain. ausperbio.com competes in a market, and the same numbers exist for everyone in it — including the sites AI engines recommend instead of yours. Amrut.ai reads all of them, so you can see who is winning, why, and what to change first.
Everything above, for your own domainand the plan to fix it
Run the free scan on your site and get its AI visibility score, its gaps, and the exact next steps.
Look up another company
A brand name or a domain — the whole overview loads in seconds.